Estudio comparativo de piperacilina/tazobactam frente a imipenem/cilastatina en la neutropenia febril (1994

Estudio comparativo de piperacilina/tazobactam frente a imipenem/cilastatina en la neutropenia febril (1994–1996)

Published:2001-01 Issue:16 Volume:116 Page:610-611
ISSN:0025-7753
Container-title:Medicina Clínica
language:es
Short-container-title:Medicina Clínica

Author:

Figuera Ángela,Pajuelo Francisco,Font Patricia,Leyra Fernando,de la Cámara Rafael,Arranz Reyes,María Fernández Rañada José,Rivero Natividad

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. Empiric antibiotic and antifungal therapy forcancer patients with prolonged fever and granulocytopenia;Pizzo;Am J Med,1982

2. Clinical experience with single agentand combination regimens in the managementof infection in the febrile neutropenic patient;Ramphal;Am J Med,1996

3. EORTC International Antimicrobial Therapy CooperativeGroup. In vitro activity of piperacillin-tazobactamagainst 365 aerobic bacteria isolatedfrom blood in granulocytopenic cancer patients;Estocolmo: International Congress of Chemotherapy,1993

4. A comparison ofimipenem to ceftazidime with or without amikacinas empiric therapy in febrile neutropenic patients;Rolston;Arch Intern Med,1992

5. A meta-analysis of clinicalstudies of imipenem-cilastatin for empiricallytreating febrile neutropenic patients;Deaney;J AntimicrobChemother,1996

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Piperacillin-tazobactam: prospects for use in real-world practice;Real-World Data & Evidence;2023-10-13

2. Piperacillin/tazobactam versus carbapenems in patients with severe bacterial infections: A systematic review with meta‐analysis;Acta Anaesthesiologica Scandinavica;2023-03-28

3. Clinical Pharmacokinetics and Pharmacodynamics of Imipenem–Cilastatin/Relebactam Combination Therapy;Clinical Pharmacokinetics;2020-02-03

4. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia;International Journal of Antimicrobial Agents;2018-09

5. β-Lactam/β-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials;Journal of Antimicrobial Chemotherapy;2014-09-25